Xiayu Li

Qiang He, Jianghua Chen, Rending Wang, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy

Jianghua Chen, Heng Li, Xiayu Li, 2017, Renal failure.

Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.

Xuelin He, Jianghua Chen, Jianghua Chen, 2014, JAMA internal medicine.

Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.

Jianghua Chen, Hui-ping Wang, Hong Shen, 2012, Clinical therapeutics.

Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis

Qiang He, Jianghua Chen, Hui-ping Wang, 2011, American Journal of Nephrology.

A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.

Qiang He, Jianghua Chen, Jianyong Wu, 2009, Clinical therapeutics.

Serum IgE Levels Are Associated With the Prognosis of Minimal Change Disease

Lefeng Wang, Heng Li, Xiayu Li, 2022, Frontiers in Immunology.

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models

Meng Li, Shi Feng, Jing Zhou, 2016, Scientific Reports.

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.

Qiang He, Jianghua Chen, L. Qu, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study

Shanshan Liu, Heng Li, Xiayu Li, 2015, BMC Nephrology.

Urine β2-Microglobulin and Retinol-Binding Protein and Renal Disease Progression in IgA Nephropathy

Jianghua Chen, Jun Cheng, Heng Li, 2021, Frontiers in Medicine.

Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis.

Jianghua Chen, Jun Cheng, Wen Zhang, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Intensive Systolic Blood Pressure Lowering and Kidney Disease Progression in IgA Nephropathy: A Cohort Study

Jianghua Chen, Jun Cheng, Heng Li, 2022, Frontiers in Medicine.

Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

Jianhua Mao, Weiqiang Lin, Jun Cheng, 2022, Frontiers in Medicine.

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

Qiang He, Jianghua Chen, Hui-ping Wang, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy

Jianghua Chen, Heng Li, Xiayu Li, 2017, Renal failure.

Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study

Jun Cheng, Heng Li, Gui-zhen Yu, 2023, Renal failure.

Deciphering three predominant biopsy-proven phenotypes of IgG4-associated kidney disease: a retrospective study

Rending Wang, Hui-ping Wang, Xiayu Li, 2024, Clinical kidney journal.